| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.60B | 21.20B | 21.18B | 21.10B | 18.72B | 17.61B |
| Gross Profit | 13.82B | 13.52B | 13.12B | 12.43B | 11.50B | 11.08B |
| EBITDA | 4.28B | 4.25B | 4.30B | 3.37B | 4.02B | -279.70M |
| Net Income | 1.89B | 1.78B | 1.93B | 1.60B | 1.76B | -2.10B |
Balance Sheet | ||||||
| Total Assets | 34.66B | 37.30B | 35.47B | 33.26B | 33.71B | 32.34B |
| Cash, Cash Equivalents and Short-Term Investments | 1.33B | 3.22B | 3.30B | 1.47B | 3.13B | 2.86B |
| Total Debt | 8.66B | 8.56B | 8.62B | 7.11B | 7.97B | 9.68B |
| Total Liabilities | 16.49B | 17.33B | 17.10B | 15.63B | 17.05B | 17.79B |
| Stockholders Equity | 17.22B | 18.80B | 17.24B | 16.54B | 15.44B | 13.27B |
Cash Flow | ||||||
| Free Cash Flow | 1.97B | 1.91B | 1.88B | 1.08B | 976.50M | 2.06B |
| Operating Cash Flow | 3.29B | 3.23B | 3.21B | 2.42B | 2.40B | 3.03B |
| Investing Cash Flow | -2.37B | -1.81B | -1.48B | -1.48B | 619.80M | -949.30M |
| Financing Cash Flow | -1.35B | -1.45B | 134.60M | -2.54B | -2.84B | -2.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €19.57B | 22.97 | 24.74% | 0.58% | 45.24% | ― | |
72 Outperform | €7.02B | 17.76 | 8.49% | ― | 3.38% | -14.57% | |
71 Outperform | €34.64B | 18.19 | 10.71% | 1.70% | 4.16% | 7.78% | |
68 Neutral | €18.92B | 23.06 | 108.18% | 2.14% | 25.95% | 17.64% | |
66 Neutral | €9.92B | 25.46 | 17.92% | 1.81% | 1.93% | 2.27% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
51 Neutral | €6.05B | ― | -12.35% | 1.23% | -4.77% | 49.72% |